OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Scientific Officer Jeffrey S. Heier sold $42K of Ocular Therapeutix, Inc.
Sold$41,767
$12.04Price
3,469Shares
−1%Stake
What OCUL did after the filing
- The stock from Wed, Nov 26 close, $12.14
- −11.9%
- S&P 500, same days
- +3.1%
Measured over 30 trading days, to the Jan 12 close.
Traded Mon, Nov 24. Filed Wed, Nov 26, 11:01 AM ET, during the session. Returns use the Nov 26 close and the Jan 12 close. Not investment advice.